Home › Categories › Corporate Reports› Immutep Report

Immutep Report.pdf

44zy9kjl9f3cq9.pdf
Preview of Immutep Report
🔗 Source: asx.com.au
📊 Size: 1.4 MB
👤 Author: Immutep
⬇️ Downloads: 69

Summary

Immutep Limited reported a loss of $29,902,624 for the year ended 30 June 2021, up from a loss of $13,468,232 in the previous year, primarily due to a decrease in licensing revenues and an increase in non-cash changes in the fair value of financial liabilities. Revenue from ordinary activities was nil, down from $7,486,444, and other income decreased to $3,968,133 from $9,013,524. No dividends were paid or declared during the period. Net tangible asset backing per ordinary security was 8.1 cents, up from 3.7 cents.

Download File

Description

Immutep Limited reported a loss of $29,902,624 for the year ended 30 June 2021, up from a loss of $13,468,232 in the previous year, primarily due to a decrease...

Technical Information

  • File Format: PDF
  • File Size: 1.4 MB
  • Pages: 86
  • Language: EN
  • Author: Immutep
  • Total Downloads: 69
  • Last Updated: 2 weeks ago

Document Overview

This PDF document about Immutep Report provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Immutep Report.

Related Topics

If you're interested in Immutep Report, you might also want to explore:

Immutep guideImmutep tutorialReport guideReport tutorial

Related Categories

Business & Finance
41204 documents
Education & Learning
22711 documents
Health & Wellness
8956 documents
Technology
4783 documents

Related Documents

Preview of Immutep Collaboration
PDF file

Immutep Collaboration

229 KBImmutepEN4 pages
Immutep Limited enters clinical trial collaboration and supply agreement with Merck KGaA and Pfizer to evaluate combining eftilagimod alpha with...
Download
Preview of Immutep Conference Updates
PDF file

Immutep Conference Updates

220 KBDeanne MillerEN2 pages
Immutep Limited will present updated clinical data from its Phase I TACTI-mel trial and new data on its pre-clinical product candidate IMP761 at...
Download
Preview of Immutep Share Plan
PDF file

Immutep Share Plan

1.06 MBDeanne MillerEN15 pages
Immutep Limited announced a $60 million two-tranche placement of new shares at A$0.52 per share, with the second tranche conditional on shareholder...
Download
Preview of Immutep Limited Updates on LAG-3 Therapeutics
PDF file

Immutep Limited Updates on LAG-3 Therapeutics

2.26 MBIMMEN33 pages
IMMP), global leader in LAG-3 therapeutics, invites you to its Virtual Healthcare Conference from June 1-4, 2021. The presentation offers a business...
Download
Preview of Immutep Limited: LAG-3 Therapeutics Update - EGM Presentation (26 July 2021)
PDF file

Immutep Limited: LAG-3 Therapeutics Update - EGM Presentation (26 July 2021)

1.43 MBIMMEN24 pages
IMMP), global leader in LAG-3 therapeutics, presents an update at its Extraordinary General Meeting on 26 July 2021, highlighting business progress...
Download

Download Immutep Report eBooks for free and learn more about Immutep Report. These books contain exercises and tutorials to improve your practical skills, at all levels!

Not satisfied with this document? We have related documents to Immutep Report, try searching with similar keywords: Immutep Report, Immutep Limited Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Fiscal Year Ended June 30, 2019, Immutep Collaboration, Immutep Share Plan, Immutep Conference Updates, Appendix 3Y: Director's Interest Change - Grant Chamberlain, IMMUTEP LIMITED, Securities Issuance and Quotation Procedures for Immutep Limited, Immutep Limited: LAG-3 Therapeutics Update - EGM Presentation (26 July 2021)

You can download PDF versions of the user's guide, manuals and ebooks about Immutep Report, you can also find and download for free A free online manual (notices) with beginner and intermediate, Downloads Documentation, You can download PDF files (or DOC and PPT) about Immutep Report for free, but please respect copyrighted ebooks.